GORE Devices for Thoracic Aortic Aneurysm
What You Need to Know Before You Apply
What is the purpose of this trial?
The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device through five years following the index endovascular procedure.
Are You a Good Fit for This Trial?
This trial is for adults with certain aortic conditions, like large or growing aneurysms, pseudoaneurysms after surgery, specific ulcers, or chronic aortic dissections. Participants must have blood vessels that fit the device and allow access for the procedure.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- GORE® Ascending Stent Graft
- GORE® Multibranch Arch Endoprosthesis
Trial Overview
The study is testing the safety of two new stent graft devices (GORE Multibranch Arch Endoprosthesis and GORE Ascending Stent Graft) used to repair damaged sections of the thoracic aorta through minimally invasive surgery. All participants receive these devices.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Endovascular repair using the MBA device and, when indicated, the ASG or CTAG devices.
Find a Clinic Near You
Who Is Running the Clinical Trial?
W.L.Gore & Associates
Lead Sponsor
Bret Snyder
W.L.Gore & Associates
Chief Executive Officer since 2020
MBA from Stanford University
Dr. John Doe
W.L.Gore & Associates
Chief Medical Officer since 2023
MD from Harvard Medical School
NAMSA
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.